These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 8891601

  • 1. Involvement of 5-HT2A receptors in the elevation of rat serum corticosterone concentrations by quipazine and MK-212.
    Hemrick-Luecke SK, Fuller RW.
    Eur J Pharmacol; 1996 Sep 12; 311(2-3):207-11. PubMed ID: 8891601
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the potency of MDL 100,907 and SB 242084 in blocking the serotonin (5-HT)(2) receptor agonist-induced increases in rat serum corticosterone concentrations: evidence for 5-HT(2A) receptor mediation of the HPA axis.
    Hemrick-Luecke SK, Evans DC.
    Neuropharmacology; 2002 Feb 12; 42(2):162-9. PubMed ID: 11804612
    [Abstract] [Full Text] [Related]

  • 3. In-vivo assessment of 5-HT2A and 5-HT2C antagonistic properties of newer antipsychotics.
    Sánchez C, Arnt J.
    Behav Pharmacol; 2000 Jun 12; 11(3-4):291-8. PubMed ID: 11103883
    [Abstract] [Full Text] [Related]

  • 4. In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist.
    Kennett GA, Wood MD, Glen A, Grewal S, Forbes I, Gadre A, Blackburn TP.
    Br J Pharmacol; 1994 Mar 12; 111(3):797-802. PubMed ID: 7912626
    [Abstract] [Full Text] [Related]

  • 5. Neurochemical and behavioral evidence that quipazine-ketanserin discrimination is mediated by serotonin2A receptor.
    Smith RL, Barrett RJ, Sanders-Bush E.
    J Pharmacol Exp Ther; 1995 Nov 12; 275(2):1050-7. PubMed ID: 7473132
    [Abstract] [Full Text] [Related]

  • 6. Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO 60-0175: a pharmacological analysis.
    Dekeyne A, Girardon S, Millan MJ.
    Neuropharmacology; 1999 Mar 12; 38(3):415-23. PubMed ID: 10219979
    [Abstract] [Full Text] [Related]

  • 7. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R, Brocco M, Audinot V, Gobert A, Veiga S, Millan MJ.
    J Pharmacol Exp Ther; 1995 Apr 12; 273(1):101-12. PubMed ID: 7714755
    [Abstract] [Full Text] [Related]

  • 8. Evidence that 5-HT2A receptors in the hypothalamic paraventricular nucleus mediate neuroendocrine responses to (-)DOI.
    Zhang Y, Damjanoska KJ, Carrasco GA, Dudas B, D'Souza DN, Tetzlaff J, Garcia F, Hanley NR, Scripathirathan K, Petersen BR, Gray TS, Battaglia G, Muma NA, Van de Kar LD.
    J Neurosci; 2002 Nov 01; 22(21):9635-42. PubMed ID: 12417689
    [Abstract] [Full Text] [Related]

  • 9. Serotonin receptor subtypes involved in the elevation of serum corticosterone concentration in rats by direct- and indirect-acting serotonin agonists.
    Fuller RW, Snoddy HD.
    Neuroendocrinology; 1990 Aug 01; 52(2):206-11. PubMed ID: 2148812
    [Abstract] [Full Text] [Related]

  • 10. 5-HT2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells.
    Van de Kar LD, Javed A, Zhang Y, Serres F, Raap DK, Gray TS.
    J Neurosci; 2001 May 15; 21(10):3572-9. PubMed ID: 11331386
    [Abstract] [Full Text] [Related]

  • 11. 5-HT2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists.
    Millan MJ, Peglion JL, Lavielle G, Perrin-Monneyron S.
    Eur J Pharmacol; 1997 Apr 23; 325(1):9-12. PubMed ID: 9151932
    [Abstract] [Full Text] [Related]

  • 12. Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats.
    Zaniewska M, McCreary AC, Przegaliński E, Filip M.
    Eur J Pharmacol; 2007 Oct 01; 571(2-3):156-65. PubMed ID: 17617403
    [Abstract] [Full Text] [Related]

  • 13. Neuroendocrine evidence that (S)-2-(chloro-5-fluoro-indol- l-yl)-1-methylethylamine fumarate (Ro 60-0175) is not a selective 5-hydroxytryptamine(2C) receptor agonist.
    Damjanoska KJ, Muma NA, Zhang Y, D'Souza DN, Garcia F, Carrasco GA, Kindel GH, Haskins KA, Shankaran M, Petersen BR, Van De Kar LD.
    J Pharmacol Exp Ther; 2003 Mar 01; 304(3):1209-16. PubMed ID: 12604698
    [Abstract] [Full Text] [Related]

  • 14. Cataleptogenic effect of subtype selective 5-HT receptor antagonists in the rat.
    Kalkman HO, Neumann V, Nozulak J, Tricklebank MD.
    Eur J Pharmacol; 1998 Feb 19; 343(2-3):201-7. PubMed ID: 9570468
    [Abstract] [Full Text] [Related]

  • 15. Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone.
    Schreiber R, Brocco M, Millan MJ.
    Eur J Pharmacol; 1994 Oct 13; 264(1):99-102. PubMed ID: 7530204
    [Abstract] [Full Text] [Related]

  • 16. 5-HT2C receptor involvement in female rat lordosis behavior.
    Wolf A, Caldarola-Pastuszka M, DeLashaw M, Uphouse L.
    Brain Res; 1999 Apr 17; 825(1-2):146-51. PubMed ID: 10216181
    [Abstract] [Full Text] [Related]

  • 17. Lack of a difference between ketanserin and ritanserin in central vs. peripheral serotonin receptor antagonism.
    Cohen ML, Bloomquist WL, Snoddy HD, Fuller RW.
    Life Sci; 1989 Apr 17; 45(13):1185-9. PubMed ID: 2507847
    [Abstract] [Full Text] [Related]

  • 18. Effects of serotonin agonists on operant behavior in the squirrel monkey: quipazine, MK-212, trifluoromethylphenylpiperazine, and chlorophenylpiperazine.
    McKearney JW.
    Pharmacol Biochem Behav; 1990 Jan 17; 35(1):181-5. PubMed ID: 2315357
    [Abstract] [Full Text] [Related]

  • 19. Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on temporal differentiation: evidence for the involvement of 5-HT2A but not 5-HT3 receptors in interval timing behaviour.
    Body S, Asgari K, Rickard JF, Zhang Z, Fone KC, Bradshaw CM, Szabadi E.
    Psychopharmacology (Berl); 2005 Sep 17; 181(2):289-98. PubMed ID: 15864559
    [Abstract] [Full Text] [Related]

  • 20. 5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects of m-chlorophenylpiperazine.
    Fiorella D, Helsley S, Rabin RA, Winter JC.
    Psychopharmacology (Berl); 1995 Dec 17; 122(3):237-43. PubMed ID: 8748393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.